Advaxis Inc.

ADXS

1.87

+0.10

+5.7%

Please Login or Register

Login|Register FREE

Stock Price
Open: 1.80
Prev. Close: 1.77
Low/Hi: 1.78 - 1.87
52-Week: 1.51 - 9.55
Volumes
Equity: 484,356
90-Day Avg: 931,724
Option: 64
90-Day Avg: 108
Volatility
Todays Stock Vol: 66.2
20-Day (HV): 78.2
52-Week (HV): 72.1
30-Day IV: 75.4 +2.2
IV Pct Rank: 97% Elevated
Fundamental
Div. Yield:
Earnings: 6-Jun (Est.)
P/E Ratio:
Market Cap: 92.6 M
Short Int Pct: 0.0%
Pct Held By Inst.: 29.4%
Stock Info
Type: Common
Sector: Healthcare
Industry: Biotechnology

About ADXS

Located in Princeton, N.J., Advaxis, Inc. is a clinical-stage biotechnology company developing multiple cancer immunotherapies based on its proprietary Lm Technology. The Lm Technology, using bioengineered live attenuated Listeria monocytogenes (Lm) bacteria, is the only known cancer immunotherapy agent shown in preclinical studies to both generate cancer fighting T-cells directed against a cancer antigen and neutralize Tregs and myeloid-derived suppressor cells (MDSCs) that protect the tumor microenvironment from immunologic attack and contribute to tumor growth. Advaxis's lead Lm Technology immunotherapy, axalimogene filolisbac, targets human papillomavirus (HPV)-associated cancers and is in clinical trials for three potential indications: Phase 2 in invasive cervical cancer, Phase 1/2 in head and neck cancer, and Phase 1/2 in anal cancer. The U.S. Food and Drug Administration (FDA) has granted axalimogene filolisbac orphan drug designation for each of these three clinical settings.
Primary Exchange: NASDAQ
SIC Pharmaceutical Preparations
NAICS Biological Product (except Diagnostic) Manufacturing

ADXS is a Holding In These ETFs:

ETF Ticker ETF Name Net Assets Net Assets Raw # Holdings # Holdings Raw Weight Weight Raw Market Value Market Value Raw
EQWS PowerShares Russell 2000 Equal Weight Portfolio 25.0 M 2.5E+07 1,927 1927 0.03% 0.00029 7 K 7170
ITOT iShares Core S&P Total U.S. Stock Market ETF 13.8 B 1.38095E+10 3,460 3460 0.0% 0 25 K 24854
IWC iShares Microcap ETF 990.7 M 9.90706E+08 1,365 1365 0.02% 0.0002 162 K 161718
IWM iShares Russell 2000 ETF 45.2 B 4.52477E+10 1,975 1975 0.0% 0 1.4 M 1406360
IWN iShares Russell 2000 Value ETF 10.0 B 9.99388E+09 1,392 1392 0.0% 0 56 K 56119
IWO iShares Russell 2000 Growth ETF 10.3 B 1.02733E+10 1,183 1183 0.01% 0.0001 547 K 547007
IWV iShares Russell 3000 ETF 8.4 B 8.41251E+09 2,930 2930 0.0% 0 15 K 15285
URTY ProShares UltraPro Russell2000 150.6 M 1.50624E+08 1,985 1985 0.0% 5.92487E-06 3 K 2982
UWM ProShares Ultra Russell2000 238.0 M 2.38022E+08 1,985 1985 0.0% 1.08308E-05 6 K 5687
VHT Vanguard Health Care ETF 7.1 B 7.1E+09 362 362 0.0% 2E-05 133 K 133006
VTI Vanguard Total Stock Market ETF 93.3 B 9.33E+10 3,629 3629 0.0% 0 172 K 171759
VTWG Vanguard Russell 2000 Growth ETF 249.3 M 2.493E+08 1,205 1205 0.01% 5E-05 12 K 12318
VTWO Vanguard Russell 2000 ETF 1.3 B 1.3E+09 2,003 2003 0.0% 3E-05 37 K 36581
VTWV Vanguard Russell 2000 Value ETF 188.8 M 1.888E+08 1,404 1404 0.0% 1E-05 954 954
VXF Vanguard Extended Market ETF 5.9 B 5.9E+09 3,259 3259 0.0% 2E-05 101 K 100591

Wait, Before You Leave...

Want to Know More About ADXS Earnings?

Receive your FREE email to get Wall Street expected earnings moves and daily upcoming earnings alerts!
Market Chameleon